These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31262040)

  • 1. Influence of
    Pujol-Moix N; Martinez-Perez A; Sabater-Lleal M; Llobet D; Vilalta N; Hamsten A; Souto JC; Soria JM
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31262040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide linkage analysis of von Willebrand factor plasma levels: results from the GAIT project.
    Souto JC; Almasy L; Soria JM; Buil A; Stone W; Lathrop M; Blangero J; Fontcuberta J
    Thromb Haemost; 2003 Mar; 89(3):468-74. PubMed ID: 12624629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The platelet function analyzer (PFA-100) may not be suitable for monitoring the therapeutic efficiency of von willebrand concentrate in type III von willebrand disease.
    Meskal A; Vertessen F; Van der Planken M; Berneman ZN
    Ann Hematol; 1999 Sep; 78(9):426-30. PubMed ID: 10525831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linkage analysis of factor VIII and von Willebrand factor loci as quantitative trait loci.
    De Visser MC; Sandkuijl LA; Lensen RP; Vos HL; Rosendaal FR; Bertina RM
    J Thromb Haemost; 2003 Aug; 1(8):1771-6. PubMed ID: 12911592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of bleeding history, von Willebrand factor and PFA-100(®) on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM-1VWD.
    Castaman G; Tosetto A; Goodeve A; Federici AB; Lethagen S; Budde U; Batlle J; Meyer D; Mazurier C; Goudemand J; Eikenboom J; Schneppenheim R; Ingerslev J; Habart D; Hill F; Peake I; Rodeghiero F
    Br J Haematol; 2010 Nov; 151(3):245-51. PubMed ID: 20738304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism.
    Tirado I; Mateo J; Soria JM; Oliver A; Martínez-Sánchez E; Vallvé C; Borrell M; Urrutia T; Fontcuberta J
    Thromb Haemost; 2005 Mar; 93(3):468-74. PubMed ID: 15735796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of increased von Willebrand factor levels on primary hemostasis in thrombocytopenic patients with liver cirrhosis.
    Wannhoff A; Müller OJ; Friedrich K; Rupp C; Klöters-Plachky P; Leopold Y; Brune M; Senner M; Weiss KH; Stremmel W; Schemmer P; Katus HA; Gotthardt DN
    PLoS One; 2014; 9(11):e112583. PubMed ID: 25397410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide studies of von Willebrand factor propeptide identify loci contributing to variation in propeptide levels and von Willebrand factor clearance.
    Ozel AB; McGee B; Siemieniak D; Jacobi PM; Haberichter SL; Brody LC; Mills JL; Molloy AM; Ginsburg D; Li JZ; Desch KC
    J Thromb Haemost; 2016 Sep; 14(9):1888-98. PubMed ID: 27359253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
    McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
    Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of platelet aggregation using a point-of-care instrument in retired racing Greyhounds.
    Couto CG; Lara A; Iazbik MC; Brooks MB
    J Vet Intern Med; 2006; 20(2):365-70. PubMed ID: 16594595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aging and ABO blood type influence von Willebrand factor and factor VIII levels through interrelated mechanisms.
    Albánez S; Ogiwara K; Michels A; Hopman W; Grabell J; James P; Lillicrap D
    J Thromb Haemost; 2016 May; 14(5):953-63. PubMed ID: 26875505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time.
    Souto JC; Almasy L; Muñiz-Diaz E; Soria JM; Borrell M; Bayén L; Mateo J; Madoz P; Stone W; Blangero J; Fontcuberta J
    Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):2024-8. PubMed ID: 10938027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the platelet function analyser (PFA-100) in the characterization of patients with von Willebrand's disease and its relationships with von Willebrand factor and the ABO blood group.
    Nitu-Whalley IC; Lee CA; Brown SA; Riddell A; Hermans C
    Haemophilia; 2003 May; 9(3):298-302. PubMed ID: 12694521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of ABO blood group on von Willebrand factor tests in healthy Saudi blood donors.
    Alharbi A; Hassan SB; Al-Momen AK; Al-Saleh K; Nasr R; Kohgear H; Owaidah T
    Blood Coagul Fibrinolysis; 2018 Mar; 29(2):211-215. PubMed ID: 29369083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of ABO blood groups on primary hemostasis.
    Moeller A; Weippert-Kretschmer M; Prinz H; Kretschmer V
    Transfusion; 2001 Jan; 41(1):56-60. PubMed ID: 11161246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a novel platelet function analyzer (PFA-100) with high sensitivity to disturbances in von Willebrand factor to screen for von Willebrand's disease and other disorders.
    Favaloro EJ; Facey D; Henniker A
    Am J Hematol; 1999 Nov; 62(3):165-74. PubMed ID: 10539883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABO blood group genotypes, plasma von Willebrand factor levels and loading of von Willebrand factor with A and B antigens.
    Morelli VM; de Visser MC; van Tilburg NH; Vos HL; Eikenboom JC; Rosendaal FR; Bertina RM
    Thromb Haemost; 2007 Apr; 97(4):534-41. PubMed ID: 17393014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The genetic basis of von Willebrand disease.
    Goodeve AC
    Blood Rev; 2010 May; 24(3):123-34. PubMed ID: 20409624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet function and ABO blood group.
    Sweeney JD; Labuzetta JW; Hoernig LA; Fitzpatrick JE
    Am J Clin Pathol; 1989 Jan; 91(1):79-81. PubMed ID: 2491926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of ABO(H) and I blood group system development with von Willebrand factor and Factor VIII plasma levels in children and adolescents.
    Klarmann D; Eggert C; Geisen C; Becker S; Seifried E; Klingebiel T; Kreuz W
    Transfusion; 2010 Jul; 50(7):1571-80. PubMed ID: 20210927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.